Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. (ticker: CDIO) is an NASDAQ-listed in vitro & in vivo diagnostic substances company. DredgeCap's structured extraction of CDIO's SEC filings surfaces 2 active risk signals, including 1 auditor-change signal, and 1 delisting/deregistration signal. CDIO reported $15K in revenue and -$6.50M for the period ending 2025-12-31, with operating cash flow of -$5.73M. Cash and equivalents stood at $0. Total assets of $7.77M exceed total liabilities of $793K. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.